Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer-Reference-Cited by-同舟云学术

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer

Published:2022-11-02 Issue:1 Volume:13 Page:1188-1200
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Murphy Neal¹²³,Shih Andrew J.⁴³,Shah Paras⁵,Yaskiv Oksana¹⁶,Khalili Houman⁴,Liew Anthony⁴,Lee Annette T.¹⁴⁷,Zhu Xin-Hua¹²⁷

Affiliation:

1. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA

2. Northwell Health Cancer Institute, Lake Success, NY 11042, USA

3. These authors contributed equally to this work and share first authorship

4. Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA

5. Mayo Clinic, Rochester, MN 55902, USA

6. Northwell Health Department of Pathology, Greenvale, NY 11548, USA

7. These authors contributed equally to this work and share last authorship

Publisher

Impact Journals, LLC

Subject

Oncology

Reference57 articles.

1. Key Statistics for Bladder Cancer. Available 2022 Feb 19, from https://www.cancer.org/cancer/bladder-cancer/about/key-statistics.html.

2. Cancer Facts & Figures 2019. American Cancer Society. Available 2019 Apr 28, from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf.

3. Bladder Cancer - Statistics. Cancer Net. 2012. Available 2019 May 5, from https://www.cancer.net/cancer-types/bladder-cancer/statistics.

4. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration;Advanced Bladder Cancer (ABC) Meta-analysis Collaboration;Eur Urol,2005

5. Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis;Drabick;Oncologist,2016